N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide

C19H28N6O3 — CID 129326259

IUPACN-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide
SMILESCC(C)n1cc(C[C@H]2NC(=O)N(CC(=O)NCCC3=CCCCC3)C2=O)nn1
InChIInChI=1S/C19H28N6O3/c1-13(2)25-11-15(22-23-25)10-16-18(27)24(19(28)21-16)12-17(26)20-9-8-14-6-4-3-5-7-14/h6,11,13,16H,3-5,7-10,12H2,1-2H3,(H,20,26)(H,21,28)/t16-/m1/s1
InChIKeyIJGBWCZIJSQGSE-MRXNPFEDSA-N
MW388.47 g/mol
LogP1.33
Rot. Bonds8

About N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide

N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide (PubChem CID 129326259) has the molecular formula C19H28N6O3 and a molecular weight of 388.47 g/mol. Its IUPAC name is N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide.

Molecular Properties

Compound NameN-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide
PubChem CID129326259
Molecular FormulaC19H28N6O3
Molecular Weight388.47 g/mol
Exact Mass388.22
IUPAC NameN-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide
SMILESCC(C)n1cc(C[C@H]2NC(=O)N(CC(=O)NCCC3=CCCCC3)C2=O)nn1
InChIInChI=1S/C19H28N6O3/c1-13(2)25-11-15(22-23-25)10-16-18(27)24(19(28)21-16)12-17(26)20-9-8-14-6-4-3-5-7-14/h6,11,13,16H,3-5,7-10,12H2,1-2H3,(H,20,26)(H,21,28)/t16-/m1/s1
InChIKeyIJGBWCZIJSQGSE-MRXNPFEDSA-N
XLogP1.33
TPSA109.22 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500388.47
LogP ≤ 51.33
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide?
The IUPAC name of N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide (CID 129326259) is N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide.
What is the SMILES notation for N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide?
The canonical SMILES for N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide is CC(C)n1cc(C[C@H]2NC(=O)N(CC(=O)NCCC3=CCCCC3)C2=O)nn1.
What is the InChIKey of N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide?
The InChIKey is IJGBWCZIJSQGSE-MRXNPFEDSA-N. The full InChI is InChI=1S/C19H28N6O3/c1-13(2)25-11-15(22-23-25)10-16-18(27)24(19(28)21-16)12-17(26)20-9-8-14-6-4-3-5-7-14/h6,11,13,16H,3-5,7-10,12H2,1-2H3,(H,20,26)(H,21,28)/t16-/m1/s1.
What are the key properties of N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide?
N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide has a molecular weight of 388.47 g/mol, XLogP of 1.33, 8 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(cyclohexen-1-yl)ethyl]-2-[(4R)-2,5-dioxo-4-[(1-propan-2-yltriazol-4-yl)methyl]imidazolidin-1-yl]acetamide is sourced from PubChem (CID 129326259), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).